Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO17557 | Hydrodictyon reticulatum | Species | Hydrodictyaceae | Eukaryota | UNPD* | |||
NPO19602 | Nephelium maingayi | Species | Sapindaceae | Eukaryota | UNPD* | |||
NPO8918 | Plantago depressa | Species | Plantaginaceae | Eukaryota | UNPD* | |||
NPO15688 | Astragalus oxyphysus | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO19801 | Euphorbia armena | Species | Euphorbiaceae | Eukaryota | UNPD* | |||
NPO18559 | Cucumaria okhotensis | Species | Cucumariidae | Eukaryota | UNPD* | |||
NPO8884 | Cuscuta reflexa | Species | Convolvulaceae | Eukaryota | UNPD* | |||
NPO19673 | Galanthus nivalis | Species | Amaryllidaceae | Eukaryota | UNPD* | |||
NPO18991 | Senecio candollei | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO19474 | Clavaria pyxidata | Species | Clavariaceae | Eukaryota | UNPD* | |||
NPO10029 | Prunus dulcis | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO19343 | Centaurea glastifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO17305 | Oenanthe phellandrium | Species | Muscicapidae | Eukaryota | UNPD* | |||
NPO14500 | Pyrus pyraster | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO19542 | Grindelia havardii | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO19214 | Polyscias scutellaria | Species | Araliaceae | Eukaryota | UNPD* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[3597642] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[2926392] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid |
PMID[2926392] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1008 | Individual Protein | GABA receptor rho-1 subunit | Homo sapiens | EC50 | = | 16000 | nM | 10780899 |
NPT1324 | Individual Protein | GABA receptor rho-2 subunit | Homo sapiens | EC50 | = | 3000 | nM | 10780899 |
NPT998 | Protein Complex | GABA-C receptor | Homo sapiens | Kb | = | 1500 | nM | 10780899 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | IC50 | = | 900 | nM | 3027337 |
NPT999 | Protein Complex | GABA-A receptor; alpha-1/beta-3/gamma-2 | Homo sapiens | EC50 | = | 310000 | nM | 11412984 |
NPT1000 | Protein Complex | GABA-A receptor; alpha-2/beta-3/gamma-2 | Homo sapiens | EC50 | = | 600000 | nM | 11412984 |
NPT1001 | Protein Complex | GABA-A receptor; alpha-3/beta-3/gamma-2 | Homo sapiens | EC50 | = | 300000 | nM | 11412984 |
NPT1002 | Protein Complex | GABA A receptor alpha-4/beta-3/gamma-2 | Homo sapiens | EC50 | = | 340000 | nM | 11412984 |
NPT1003 | Protein Complex | GABA-A receptor; alpha-5/beta-3/gamma-2 | Homo sapiens | EC50 | = | 420000 | nM | 11412984 |
NPT1004 | Protein Complex | GABA-A receptor; alpha-6/beta-3/gamma-2 | Homo sapiens | EC50 | = | 460000 | nM | 11412984 |
NPT1007 | Protein Complex | GABA-A receptor; alpha-1/beta-2/gamma-2 | Homo sapiens | EC50 | = | 138000 | nM | 17655213 |
NPT2 | Others | Unspecified | Ki | = | 650 | nM | 17655213 | |
NPT2 | Others | Unspecified | Ki | = | 630.96 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 13000 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 7.94E+13 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 5500 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 5011.87 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 100000 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 5495.41 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 20000 | nM | 17655213 | |
NPT2 | Others | Unspecified | EC50 | = | 19952.62 | nM | 17655213 | |
NPT1007 | Protein Complex | GABA-A receptor; alpha-1/beta-2/gamma-2 | Homo sapiens | EC50 | = | 138038.43 | nM | 17655213 |
NPT1008 | Individual Protein | GABA receptor rho-1 subunit | Homo sapiens | Kb | = | 1700 | nM | 18528996 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | = | 398.1 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT95 | Individual Protein | Muscarinic acetylcholine receptor M1 | Rattus norvegicus | Potency | = | 63.1 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 9466.2 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | AC50 | = | 31622.78 | nM | PubChem BioAssay data set |
NPT813 | Individual Protein | GABA transporter 1 | Mus musculus | IC50 | = | 616595 | nM | 21353350 |
NPT815 | Individual Protein | GABA transporter 3 | Mus musculus | IC50 | = | 102329.3 | nM | 21353350 |
NPT816 | Individual Protein | GABA transporter 4 | Mus musculus | IC50 | = | 17378.01 | nM | 21353350 |
NPT2 | Others | Unspecified | IC50 | = | 46773.51 | nM | 21353350 | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 26654.1 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 2310 | nM | PubChem BioAssay data set | |
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 37933 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC15566 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.872 | High Similarity | NPC235501 |
0.8385 | Intermediate Similarity | NPC237812 |
0.8385 | Intermediate Similarity | NPC18223 |
0.8358 | Intermediate Similarity | NPC174020 |
0.8333 | Intermediate Similarity | NPC185903 |
0.8319 | Intermediate Similarity | NPC327613 |
0.8281 | Intermediate Similarity | NPC25465 |
0.8195 | Intermediate Similarity | NPC286696 |
0.7899 | Intermediate Similarity | NPC327477 |
0.7863 | Intermediate Similarity | NPC111132 |
0.782 | Intermediate Similarity | NPC126634 |
0.7731 | Intermediate Similarity | NPC155498 |
0.7721 | Intermediate Similarity | NPC210947 |
0.7692 | Intermediate Similarity | NPC180462 |
0.7565 | Intermediate Similarity | NPC9639 |
0.7519 | Intermediate Similarity | NPC243319 |
0.7463 | Intermediate Similarity | NPC470138 |
0.725 | Intermediate Similarity | NPC326248 |
0.725 | Intermediate Similarity | NPC187191 |
0.719 | Intermediate Similarity | NPC273327 |
0.7122 | Intermediate Similarity | NPC470140 |
0.7114 | Intermediate Similarity | NPC60537 |
0.6972 | Remote Similarity | NPC470139 |
0.6643 | Remote Similarity | NPC246193 |
0.6613 | Remote Similarity | NPC293163 |
0.6515 | Remote Similarity | NPC313547 |
0.6457 | Remote Similarity | NPC59314 |
0.6429 | Remote Similarity | NPC144223 |
0.6316 | Remote Similarity | NPC41958 |
0.6304 | Remote Similarity | NPC470142 |
0.6261 | Remote Similarity | NPC237936 |
0.625 | Remote Similarity | NPC68938 |
0.625 | Remote Similarity | NPC278549 |
0.625 | Remote Similarity | NPC197068 |
0.6222 | Remote Similarity | NPC63433 |
0.6218 | Remote Similarity | NPC282531 |
0.6159 | Remote Similarity | NPC8590 |
0.6149 | Remote Similarity | NPC470141 |
0.6136 | Remote Similarity | NPC313504 |
0.6033 | Remote Similarity | NPC190949 |
0.6014 | Remote Similarity | NPC240084 |
0.5985 | Remote Similarity | NPC148385 |
0.5955 | Remote Similarity | NPC201900 |
0.5952 | Remote Similarity | NPC51000 |
0.5933 | Remote Similarity | NPC194541 |
0.5929 | Remote Similarity | NPC252603 |
0.5909 | Remote Similarity | NPC476099 |
0.5894 | Remote Similarity | NPC62151 |
0.589 | Remote Similarity | NPC124276 |
0.5828 | Remote Similarity | NPC314646 |
0.5814 | Remote Similarity | NPC477119 |
0.5814 | Remote Similarity | NPC320256 |
0.5797 | Remote Similarity | NPC199790 |
0.5795 | Remote Similarity | NPC477118 |
0.5772 | Remote Similarity | NPC57279 |
0.5763 | Remote Similarity | NPC477120 |
0.5742 | Remote Similarity | NPC315642 |
0.5742 | Remote Similarity | NPC74306 |
0.5714 | Remote Similarity | NPC473646 |
0.5699 | Remote Similarity | NPC282247 |
0.5695 | Remote Similarity | NPC327941 |
0.5693 | Remote Similarity | NPC312187 |
0.5693 | Remote Similarity | NPC4837 |
0.5672 | Remote Similarity | NPC476562 |
0.5634 | Remote Similarity | NPC158847 |
0.563 | Remote Similarity | NPC119133 |
0.5616 | Remote Similarity | NPC180493 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC15566 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8699 | High Similarity | NPD300 | Approved |
0.8385 | Intermediate Similarity | NPD9133 | Approved |
0.8106 | Intermediate Similarity | NPD9628 | Approved |
0.8074 | Intermediate Similarity | NPD9183 | Clinical (unspecified phase) |
0.7941 | Intermediate Similarity | NPD1451 | Approved |
0.7863 | Intermediate Similarity | NPD8861 | Approved |
0.7863 | Intermediate Similarity | NPD8862 | Approved |
0.7863 | Intermediate Similarity | NPD8859 | Approved |
0.7698 | Intermediate Similarity | NPD9627 | Approved |
0.7536 | Intermediate Similarity | NPD875 | Clinical (unspecified phase) |
0.7519 | Intermediate Similarity | NPD9081 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3697 | Discontinued |
0.7188 | Intermediate Similarity | NPD9132 | Discontinued |
0.7162 | Intermediate Similarity | NPD1731 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD2604 | Approved |
0.7114 | Intermediate Similarity | NPD2180 | Approved |
0.7014 | Intermediate Similarity | NPD5342 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD3130 | Discontinued |
0.6781 | Remote Similarity | NPD3706 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD1388 | Phase 1 |
0.6765 | Remote Similarity | NPD1389 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD1390 | Phase 1 |
0.6667 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.6624 | Remote Similarity | NPD5768 | Phase 2 |
0.6571 | Remote Similarity | NPD1807 | Clinical (unspecified phase) |
0.6457 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.6443 | Remote Similarity | NPD566 | Approved |
0.6443 | Remote Similarity | NPD568 | Approved |
0.6443 | Remote Similarity | NPD567 | Approved |
0.6442 | Remote Similarity | NPD3105 | Discontinued |
0.6327 | Remote Similarity | NPD1808 | Phase 1 |
0.6324 | Remote Similarity | NPD9360 | Approved |
0.6261 | Remote Similarity | NPD8185 | Discontinued |
0.6261 | Remote Similarity | NPD8186 | Phase 1 |
0.6197 | Remote Similarity | NPD515 | Phase 1 |
0.619 | Remote Similarity | NPD1120 | Approved |
0.619 | Remote Similarity | NPD1121 | Approved |
0.6165 | Remote Similarity | NPD8955 | Approved |
0.6165 | Remote Similarity | NPD8954 | Approved |
0.6081 | Remote Similarity | NPD576 | Discontinued |
0.6077 | Remote Similarity | NPD340 | Approved |
0.6077 | Remote Similarity | NPD341 | Approved |
0.6043 | Remote Similarity | NPD307 | Approved |
0.6014 | Remote Similarity | NPD1368 | Approved |
0.5987 | Remote Similarity | NPD1431 | Approved |
0.5987 | Remote Similarity | NPD1430 | Approved |
0.5952 | Remote Similarity | NPD8838 | Approved |
0.5944 | Remote Similarity | NPD579 | Clinical (unspecified phase) |
0.5929 | Remote Similarity | NPD9288 | Approved |
0.5929 | Remote Similarity | NPD9292 | Approved |
0.5929 | Remote Similarity | NPD76 | Approved |
0.5929 | Remote Similarity | NPD9289 | Approved |
0.5918 | Remote Similarity | NPD9650 | Phase 3 |
0.5909 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.5882 | Remote Similarity | NPD9375 | Discontinued |
0.5873 | Remote Similarity | NPD9210 | Phase 2 |
0.5873 | Remote Similarity | NPD7465 | Suspended |
0.587 | Remote Similarity | NPD757 | Phase 3 |
0.5857 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5849 | Remote Similarity | NPD7842 | Phase 2 |
0.5844 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5839 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.5765 | Remote Similarity | NPD3347 | Clinical (unspecified phase) |
0.5755 | Remote Similarity | NPD9374 | Approved |
0.5742 | Remote Similarity | NPD582 | Approved |
0.5731 | Remote Similarity | NPD1037 | Clinical (unspecified phase) |
0.5725 | Remote Similarity | NPD9373 | Approved |
0.5722 | Remote Similarity | NPD459 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD8641 | Approved |
0.5707 | Remote Similarity | NPD8261 | Discontinued |
0.5687 | Remote Similarity | NPD3708 | Phase 2 |
0.5679 | Remote Similarity | NPD1027 | Approved |
0.5679 | Remote Similarity | NPD1030 | Approved |
0.5679 | Remote Similarity | NPD1029 | Clinical (unspecified phase) |
0.5664 | Remote Similarity | NPD9409 | Discontinued |
0.5659 | Remote Similarity | NPD460 | Discontinued |
0.5634 | Remote Similarity | NPD9606 | Approved |
0.563 | Remote Similarity | NPD9291 | Approved |
0.5617 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.5616 | Remote Similarity | NPD9544 | Approved |
0.5616 | Remote Similarity | NPD78 | Approved |
0.5613 | Remote Similarity | NPD1118 | Discontinued |
0.561 | Remote Similarity | NPD695 | Discontinued |
0.561 | Remote Similarity | NPD1303 | Phase 1 |
0.5608 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.5608 | Remote Similarity | NPD1354 | Approved |
0.5608 | Remote Similarity | NPD1356 | Approved |
PubChem CID   | 96215;28305488 |
ChEMBL   | CHEMBL784 |
ZINC   |
Molecular Weight:   | 126.04 |
ALogP:   | -0.6254 |
MLogP:   | 1.57 |
XLogP:   | -0.066 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 65.98 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 9 |